Organ transplant recipients remain vulnerable to COVID-19 even after second vaccine dose: Study
ANI |
Updated: May 07, 2021 08:47 IST
Washington [US], May 7 (ANI): Researchers at Johns Hopkins have found that two doses of a vaccine against SARS-CoV-2 -- the virus that causes COVID-19 -- confers some protection for people who have received solid organ transplants, it's still not enough to enable them to dispense with COVID safety measures including masks and physical distancing.
The findings that were published in the Journal of the American Medical Association (JAMA).
This is a follow-up study to an earlier one published in March in JAMA, in which the researchers reported that only 17 per cent of the participating transplant recipients produced sufficient antibodies after just one dose of a two-dose COVID-19 vaccine regimen.